Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic review of literature;Incidence de la tuberculose chez les patients atteints de polyarthrite rhumatoïde. Revue systématique de la littérature

Revue du Rhumatisme (Edition Francaise)

Volumn 78, Issue 2, 2011, Pages 140-146

  Baronnet, Laurence ^a   Barnetche, Thomas ^a   Kahn, Valentine ^a   Lacoin, Claire ^a   Richez, Christophe ^a   Schaeverbeke, Thierry ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952607768     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2010.09.018     Document Type: Article

References (27)

1. M.A. Gardam, E.C. Keystone, and R. Menzies Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management Lancet Infect Dis 3 2003 148 155 (Pubitemid 36278124)
2. Recommandations nationales, prévention et prise en charge des tuberculoses survenant sous anti-TNF. In: Afssaps, éd. 2005.
3. Antoine D. Épidémiologie de la tuberculose en France et en Europe. In: Sanitaire Idv, éd. 2006.
4. Global tuberculosis control surveillance, planning, financing. In: Organization WH, ed. 2008.
5. F. Wolfe, K. Michaud, and J. Anderson Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy Arthritis Rheum 50 2004 372 379 (Pubitemid 38198820)
6. L. Carmona, C. Hernandez-Garcia, and C. Vadillo Increased risk of tuberculosis in patients with rheumatoid arthritis J Rheumatol 30 2003 1436 1439 (Pubitemid 36835436)
7. T. Yamada, A. Nakajima, and E. Inoue Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan Ann Rheum Dis 65 2006 1661 1663 (Pubitemid 44799684)
8. P. Brassard, A.M. Lowe, and S. Bernatsky Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada Arthritis Rheum 61 2009 300 304
9. L. Carmona, J.J. Gomez-Reino, and V. Rodriguez-Valverde Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists Arthritis Rheum 52 2005 1766 1772 (Pubitemid 40852885)
10. R.S. Wallis, M.S. Broder, and J.Y. Wong Granulomatous infectious diseases associated with tumor necrosis factor antagonists Clin Infect Dis 38 2004 1261 1265 (Pubitemid 38608568)
11. er janvier 2000 au 30 juin 2003 Presse Med 34 2005 353 357 (Pubitemid 40392969)
12. J. Askling, C.M. Fored, and L. Brandt Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden Arthritis Rheum 52 2005 1986 1992 (Pubitemid 40994319)
13. L. Sichletidis, L. Settas, and D. Spyratos Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis Int J Tuberc Lung Dis 10 2006 1127 1132 (Pubitemid 44519351)
14. F. Tubach, D. Salmon, and P. Ravaud Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry Arthritis Rheum 60 2009 1884 1894
15. W.G. Dixon, K.L. Hyrich, and K.D. Watson Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) Ann Rheum Dis 69 2010 522 528
16. P. Brassard, A. Kezouh, and S. Suissa Antirheumatic drugs and the risk of tuberculosis Clin Infect Dis 43 2006 717 722 (Pubitemid 44330734)
17. J.J. Gomez-Reino, L. Carmona, and V. Valverde Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report Arthritis Rheum 48 2003 2122 2127 (Pubitemid 36959191)
18. A.K. Mohan, T.R. Cote, and J.A. Block Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor Clin Infect Dis 39 2004 295 299 (Pubitemid 39050474)
19. W.G. Dixon, K. Watson, and M. Lunt Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 54 2006 2368 2376 (Pubitemid 44204996)
20. J. Listing, A. Strangfeld, and S. Kary Infections in patients with rheumatoid arthritis treated with biologic agents Arthritis Rheum 52 2005 3403 3412 (Pubitemid 41612206)
21. S. Bernatsky, M. Hudson, and S. Suissa Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis Rheumatology (Oxford) 46 2007 1157 1160 (Pubitemid 47050621)
22. T. Bongartz, A.J. Sutton, and M.J. Sweeting Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2006 2275 2285 (Pubitemid 43736578)
23. J.D. Greenberg, G. Reed, and J.M. Kremer Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry Ann Rheum Dis 69 2010 380 386
24. A. Ruyssen-Witrand, B. Fautrel, and A. Saraux Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review Joint Bone Spine 77 2010 246 251
25. S.S. Jick, E.S. Lieberman, and M.U. Rahman Glucocorticoid use, other associated factors, and the risk of tuberculosis Arthritis Rheum 55 2006 19 26 (Pubitemid 43235123)
26. P. Caramaschi, L.M. Bambara, and S. Pieropan Anti-TNFalpha blockers, autoantibodies and autoimmune diseases Joint Bone Spine 76 2009 333 342
27. A. Bruns, P. Nicaise-Roland, and G. Hayem Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis Joint Bone Spine 77 2009 248 253